Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice

Biochemical and Biophysical Research Communications

Volumn 412, Issue 2, 2011, Pages 296-301

  Koshinaka, Keiichi ^a   Toshinai, Koji ^a   Mohammad, Arif ^a   Noma, Kenji ^a   Oshikawa, Miki ^a   Ueno, Hiroaki ^a   Yamaguchi, Hideki ^a   Nakazato, Masamitsu ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Ghrelin; Growth hormone; Mice; Muscle atrophy

Indexed keywords

CORTICOSTERONE; GHRELIN; GROWTH HORMONE; MESSENGER RNA; SOMATOMEDIN C; STAT5 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; FOOD INTAKE; GROWTH HORMONE BLOOD LEVEL; HINDLIMB; IMMOBILIZATION; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE MASS; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SINGLE DRUG DOSE; SOLEUS MUSCLE;

ANIMALS; GHRELIN; HINDLIMB SUSPENSION; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C57BL; MUSCULAR ATROPHY; RNA, MESSENGER; STAT5 TRANSCRIPTION FACTOR;

MUS;

EID: 80052022803     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.086     Document Type: Article

References (24)

1. Jagoe R.T., Goldberg A.L. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?. Curr. Opin. Clin. Nutr. Metab. Care 2001, 4:183-190.
2. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
3. Date Y., Toshinai K., Koda S., Miyazato M., Shimbara T., Tsuruta T., Niijima A., Kangawa K., Nakazato M. Peripheral interaction of ghrelin with cholecystokinin on feeding regulation. Endocrinology 2005, 146:3518-3525.
4. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001, 409:194-198.
5. Velloso C.P. Regulation of muscle mass by growth hormone and IGF-1. Br. J. Pharmacol. 2008, 154:557-568.
6. Nagaya N., Uematsu M., Kojima M., Ikeda Y., Yoshihara F., Shimizu W., Hosoda H., Hirota Y., Ishida H., Mori H., Kangawa K. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardic cachexia in rats with heart failure. Circulation 2001, 104:1430-1435.
7. Strassburg S., Anker S.D., Castaneda T.R., Burget L., Perez-Tilve D., Pfluger P.T., Nogueiras R., Halem H., Dong J.Z., Culler M.D., Datta R., Tschöp M.H. Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E78-E84.
8. Tschöp M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents, Nature 2000, 407:908-913.
9. Nagaya N., Moriya J., Yasumura Y., Uematsu M., Ono F., Shimizu W., Ueno K., Kitakaze M., Miyatake K., Kangawa K. Effects of ghrelin administration on left ventricular function. Exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004, 110:3674-3679.
10. DeBoer M.D., Zhu X.X., Levasseur P., Meguid M.M., Suzuki S., Inui A., Taylor J.E., Halem H.A., Dong J.Z., Datta R., Culler M.D., Marks D.L. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 2007, 148:3004-3012.
11. DeBoer M.D., Zhu X., Levasseur P.R., Inui A., Hu Z., Han G., Mitch W.E., Taylor J.E., Halem H.A., Dong J.Z., Datta R., Culler M.D., Marks D.L. Ghrelin treatment of chronic kidney disease: Improvements in lean body mass and cytokine profile. Endocrinology 2008, 149:827-835.
12. Ariyasu H., Iwakura H., Yamada G., Nakao K., Kangawa K., Akamizu T. Efficacy of ghrelin as a therapeutic approach for age-related physiological changes. Endocrinology 2008, 149:3722-3728.
13. Yimlamai T., Dodd S.L., Borst S.E., Park S. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. J. Appl. Physiol. 2005, 99:71-80.
14. Bodine S.C., Latres E., Baumhueter S., Lai V.K.-M., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., Pan Z.-Q., Valenzuela D.M., DeChiara T.M., Stitt T.N., Yancopoulos G.D., Glass D.J. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 23:1704-1708.
15. Vestergaard E.T., Gormsen L.C., Jessen N., Lund S., Hansen T.K., Moller N., Jorgensen J.O.L. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes 2008, 57:3205-3210.
16. Thirone A.C.P., Carvalho C.R.O., Saad M.J.A. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues. Endocrinology 1999, 140:55-62.
17. Jessen N., Djurhuus C.B., Jorgensen J.O.L., Jensen L.S., Moller N., Lund S., Schmitz O. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E194-E199.
18. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Sciaffino S., Lecker S.H., Goldberg A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412.
19. Bodine S.C., Stitt T.N., Gonzalez M., Kline W.O., Stover G.L., Bauerlein R., Zlotchenko E., Scrimgeour A., Lawrence J.C., Glass D.J., Yancopoulos G.D. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 2001, 3:1014-1019.
20. Metlakunta A.S., Sahu M., Sahu A. Hypothalamic phosphatidylinositol 3-kinase pathway of leptin signaling is impaired during the development of diet-induced obesity in FVB/N mice. Endocrinology 2008, 149:1121-1128.
21. Granado M., Priego T., Murtin A.I., Villanua M.A., Lopez-Calderon A. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle. Am. J. Endocrinol. Metab. 2005, 288:E1007-E1014.
22. Balasubramaniam A., Joshi R., Su C., Friend L.A., Sheriff S., Kagan R.J., James J.H. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R893-R901.
23. Caron A.Z., Drouin G., Desrosiers J., Trensz F., Grenier G. A novel hindlimb immobilization procedure for studying skeletal muscle atrophy and recovery in mouse. J. Appl. Physiol. 2009, 106:2049-2059.
24. Granado M., Priego T., Murtin A.I., Villanua M.A., Lopez-Calderon A. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E486-E492.